Hotline: 1800 102 2007
X
Search Business Opportunities
Mar, 18 2017

Innoplexus enters an academic collaboration with Regional Cancer Centre (RCC), Gwalior

Innoplexus will provide an academic license to doctors and researchers at RCC, Gwalior, under the association, allowing them free access to its cloud-based decision support platform, iPlexusTM.

Innoplexus, the technology and product development company focused on AI and advanced analytics, has announced a collaboration with Regional Cancer Centre (RCC), Gwalior. 

Innoplexus will provide an academic license to doctors and researchers at RCC, Gwalior, under the association, allowing them free access to its cloud-based decision support platform, iPlexusTM. 

With over 100+ terabytes of indexed scientific data available to them at their fingertips, researchers at RCC will be able to gain insights into the latest advancements in research and trials related to cancer and make swift, agile decisions pertinent to their R&D endeavours.

Dr. Gunjan Bhardwaj, Founder and Chairman, Innoplexus, said, "We are extremely delighted to announce our academic partnership with Regional Cancer Centre, Gwalior, which is in line with our vision to make access to insights real-time, comprehensive, and cost-effective.

"The need of the hour for medical research is to leverage machine learning, AI, and big data to generate continuous intelligence. This is what our recently launched iPlexusTM platform enables. We are confident that the partnership will streamline the discovery and analysis for researchers and doctors at RCC, Gwalior, and assist them in elevating their cancer-related research to another level."

Dr. B.R. Srivastava, Regional Cancer Centre, Gwalior, added, "Some of the most challenging issues facing research today are heavy data fragmentation and scattered availability of relevant information. This is something that iPlexusTM can solve with its innovative, tech-driven approach. 

"This technology has the potential to transform biomedical research by enabling swift access to relevant and credible information to researchers, allowing them to make agile decisions swiftly and effortlessly."

iPlexusTM has already been heralded as a game-changing development in the biomedical sector, and can benefit R&D and commercial teams associated with pharmaceutical companies, policymaking, clinicians, and research institutes.

Comment
Related opportunities
  • Mobile & Communication/Internet Connections
    About Us: In 2009 Gerardo Taglianetti, founded Phonup amongst first companies  in..
    Locations looking for expansion Delhi
    Establishment year 2009
    Franchising Launch Date 2017
    Investment size Rs. 10lac - 20lac
    Space required 100
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • Others Entertainment & Leisure
    About Us: Started in 2017, IronHood fitness is a premium gym..
    Locations looking for expansion Delhi
    Establishment year 2017
    Franchising Launch Date 2018
    Investment size Rs. 1 Cr. - 2 Cr
    Space required 3000
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • Robotics & Technical Training
    About Us : We would like to introduce ourselves as an..
    Locations looking for expansion Maharashtra
    Establishment year 2013
    Franchising Launch Date 2018
    Investment size Rs. 20lac - 30lac
    Space required 1000
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Mumbai Maharashtra
  • Gyms and Fitness Centres
    About Us: Trugym is an innovative gym operator from the UK...
    Locations looking for expansion Delhi
    Establishment year 2009
    Franchising Launch Date 2018
    Investment size Rs. 1 Cr. - 2 Cr
    Space required 3000
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
Insta-Subscribe to
The Franchising World
Magazine
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities